PhRMA Unveils Direct-to-Patient Drug Platform to Address Pricing and Access
AI-Generated Summary
The U.S. pharmaceutical lobby group PhRMA announced plans to launch AmericasMedicines.com, a new website in January enabling patients to purchase prescription drugs directly from manufacturers. This initiative aims to bypass pharmacy benefit managers and reduce out-of-pocket costs, coming as a direct response to mounting pressure from the Trump administration to lower drug prices and simplify patient access.
In a nutshell
This move signifies a strategic shift by the pharmaceutical industry to directly address drug pricing and access concerns, potentially reshaping the distribution landscape and patient-manufacturer interactions. It highlights the industry's proactive efforts to mitigate political and public pressure, while also challenging established intermediaries in the drug supply chain.
Source: Reuters
